Antibodies
15 November 2014
Genzyme’s Lemtrada Approved by the FDA14 November 2014
FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer13 November 2014
Sotatercept Data from the Phase 2a Clinical Trial in Hemodialysis Patients Presented at the American Society of Nephrology Kidney Week 201411 November 2014
Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab11 November 2014
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma10 November 2014
FDA Accepts Amgen’s Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab10 November 2014
Very good results of Civacir® (Hepatitis C Immune Globulin) US Phase III clinical trial7 November 2014
Genmab Announces Additional Data from Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL6 November 2014
Lilly’s CYRAMZA® (ramucirumab) in Combination with Paclitaxel Granted FDA Approval for Advanced Gastric Cancer After Prior Chemotherapy4 November 2014
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis4 November 2014
XOMA Initiates Pivotal Phase 3 Gevokizumab Study in Patients With Pyoderma Gangrenosum4 November 2014
Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer4 November 2014
Alder BioPharmaceuticals Initiates Phase 2b Clinical Trial of ALD403 for Preventative Treatment of Chronic Migraine1 November 2014
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review30 October 2014
Baxter’s Investigational 20% Subcutaneous Immunoglobulin Treatment Meets Efficacy and Tolerability Endpoints in Phase 2/3 Study30 October 2014
IMMUNOMEDICS PROVIDES UPDATE ON PHASE 2 STUDY OF ISACTUZUMAB GOVITECAN IN PATIENTS WITH DIVERSE METASTATIC SOLID CANCERSNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports